Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer?
Highlights
- This study suggests that prognosis/survival would be the same irrespective of gender in MSI vs. MSS colo-rectal cancer
- further investigations, with impact on therapeutic strategy, are however necessary
Abstract
:Highlights
- This study suggests that prognosis/ survival would be the same irrespective of gender in MSI vs. MSS colo-rectal cancer
- further investigations, with impact on therapeutic strategy, are however necessary
Abstract
Introduction
Materials and methods
Statistical analysis
Results
Discussion
MSI testing
Conclusions
Acknowledgment
References
- Boland, C.R. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer. 2005, 4, 211–218. [Google Scholar] [CrossRef] [PubMed]
- Kane, M.F.; Loda, M.; Gaida, G.M.; Lipman, J.; Mishra, R.; Goldman, H.; Jessup, J.M.; Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57, 808–811. [Google Scholar] [PubMed]
- Weitz, J.; Koch, M.; Debus, J.; Hohler, T.; Galle, P.R.; Büchler, M.W. Colorectal cancer. Lancet 2005, 365, 153–165. [Google Scholar] [CrossRef] [PubMed]
- Duval, A.; Hamelin, R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002, 62, 2447–2454. [Google Scholar] [PubMed]
- Hemminki, A.; Peltomaki, P.; Mecklin, J.P.; Jarvinen, H.; Salovaara, R.; Nystrom-Lahti, M.; de la Chapelle, A.; Aaltonen, L.A. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet. 1994, 8, 405–410. [Google Scholar] [CrossRef] [PubMed]
- Boland, C.R.; Goel, A. Microsatellite Instability in Colorectal Cancer. Gastroenterology 2010, 138, 2073–2087.e3. [Google Scholar] [CrossRef] [PubMed]
- Andre, T.; Boni, C.; Mounedji-Boudiaf, L.; Navarro, M.; Tabernero, J.; Hickish, T.; Topham, C.; Zaninelli, M.; Clingan, P.; Bridgewater, J.; Tabah-Fisch, I.; de Gramont, A.; Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, Fluorouracil, and leucovorinas adjuvant treatment for colon cancer. New Engl J Med. 2004, 350, 2343–2351. [Google Scholar] [CrossRef] [PubMed]
- Popat, S.; Hubner, R.; Houlston, R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005, 23, 609–618. [Google Scholar] [CrossRef] [PubMed]
- Duval, A.; Hamelin, R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002, 62, 2447–2454. [Google Scholar] [PubMed]
- Lindor, N.M.; Burgart, L.J.; Leontovich, O.; Goldberg, R.M.; Cunningham, J.M.; Sargent, D.J.; Walsh-Vockley, C.; Petersen, G.M.; Walsh, M.D.; Leggett, B.A.; Young, J.P.; Barker, M.A.; Jass, J.R.; Hopper, J.; Gallinger, S.; Bapat, B.; Redston, M.; Thibodeau, S.N. Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors. J Clin Oncol. 2002, 20, 1043–1048. [Google Scholar] [CrossRef] [PubMed]
- Yiu, R.; Qiu, H.; Lee, S.H.; Garcia-Aguilar, J. Mechanisms of microsatellite instability in colorectal cancer patients in different age groups. Dis Colon Rectum. 2005, 48, 2061–2069. [Google Scholar] [CrossRef] [PubMed]
- Yearsley, M.; Hampel, H.; Lehman, A.; Nakagawa, H.; de la Chapelle, A.; Frankel, W.L. Histologic features distinguish microsatellite-high from microsatellite- low and microsatellite- stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol. 2006, 37, 831–838. [Google Scholar] [CrossRef] [PubMed]
- Liu, B.; Farrington, S.M.; Petersen, G.M.; Hamilton, S.R.; Parsons, R.; Papadopoulos, N.; Fujiwara, T.; Jen, J.; Kinzler, K.W.; Wyllie, A.H.; Vogelstein, B.; Dunlop, M.G.; et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med. 1995, 1, 348–352. [Google Scholar] [CrossRef] [PubMed]
- Farrington, S.M.; Lin-Goerke, J.; Ling, J.; Wang, Y.; Burczak, J.D.; Robbins, D.J.; Dunlop, M.G. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet. 1998, 63, 749–759. [Google Scholar] [CrossRef] [PubMed]
- Alling, K.C.; French, A.J.; McDonnell, S.K.; Burgart, L.J.; Schaid, D.J.; Peterson, B.J.; Moon-Tasson, L.; Mahoney, M.R.; Sargent, D.J.; O'Connell, M.J.; Witzig, T.E.; Farr GHJr Goldberg, R.M.; Thibodeau, S.N. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst. 1999, 91, 1295–1303. [Google Scholar] [CrossRef] [PubMed]
- Aaltonen, L.A.; Salovarra, R.; Kristo, P.; Canzian, F.; Hemminki, A.; Peltomäki, P.; Chadwick, R.B.; Kääriäinen, H.; Eskelinen, M.; Järvinen, H.; Mecklin, J.P.; de la Chapelle, A. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998, 338, 1481–1487. [Google Scholar] [CrossRef] [PubMed]
- Bonadona, V.; Bonaiti, B.; Olschwang, S.; Grandjouan, S.; Huiart, L.; Longy, M.; Guimbaud, R.; Buecher, B.; Bignon, Y.J.; Caron, O.; Colas, C.; Noguès, C.; Lejeune- Dumoulin, S.; Olivier-Faivre, L.; Polycarpe-Osaer, F.; Nguyen, T.D.; Desseigne, F.; Saurin, J.C.; Berthet, P.; Leroux, D.; Duffour, J.; Manouvrier, S.; Frébourg, T.; Sobol, H.; Lasset, C.; Bonaïti-Pellié, C.; French Cancer Genetics, Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011, 305, 2304–2310. [Google Scholar] [CrossRef] [PubMed]
- Domingo, E.; Laiho, P.; Ollikainen, M.; Pinto, M.; Wang, L.; French, A.J.; Westra, J.; Frebourg, T.; Espín, E.; Armengol, M.; Hamelin, R.; Yamamoto, H.; Hofstra, R.M.; Seruca, R.; Lindblom, A.; Peltomäki, P.; Thibodeau, S.N.; Aaltonen, L.A.; Schwartz, S., Jr. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004, 41, 664–668. [Google Scholar] [CrossRef] [PubMed]
- Abdulovic, A.L.; Hile, S.E.; Kunkel, T.A.; Eckert, K.A. The in vitro fidelity of yeast DNA polymerase δ and polymerase ɛ holoenzymes during dinucleotide microsatellite DNA synthesis. DNA Repair (Amst). 2011, 10, 497–505. [Google Scholar] [CrossRef] [PubMed]
- Dolcetti, R.; Viel, A.; Doglioni, C.; Russo, A.; Guidoboni, M.; Capozzi, E.; Vecchiato, N.; Macrì, E.; Fornasarig, M.; Boiocchi, M. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosisin colorectal carcinomas with microsatellite instability. Am J Pathol 154, 1805–1813. [CrossRef] [PubMed]
- Deschoolmeester, V.; Baay, M.; Marck, E.V.; Weyler, J.; Vermeulen, P.; Filip Lardon, J.; Vermorken, R. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol. 2010, 11, 19. [Google Scholar] [CrossRef] [PubMed]
- Boland, C.R.; Thibodeau, S.N.; Hamilton, S.R.; Sidransky, D.; Eshleman, J.R.; Burt, R.W.; Meltzer, S.J.; Rodriguez-Bigas, M.A.; Fodde, R.; Ranzani, G.N.; Srivastava, S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58, 5248–5257. [Google Scholar] [PubMed]
- Moertel, C.G.; Fleming, T.R.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A.; Tangen, C.M.; Ungerleider, J.S.; Emerson, W.A.; Tormey, D.C.; Glick, J.H.; Veeder, M.H.; Mailliard, J.A. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med. 1995, 122, 321–326. [Google Scholar] [CrossRef] [PubMed]
- Galateanu, B.; Hudita, A.; Negrei, C.; Ion, R.M.; Costache, M.; Stan, M.; Nikitovic, D.; Hayes, A.W.; Spandidos, D.A.; Tsatsakis, A.M.; Ginghina, O. Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response. Int J Oncol. 2016, 48, 2295–2302. [Google Scholar] [CrossRef] [PubMed]
- Samowitz, W.S.; Curtin, K.; Ma, K.N.; Schaffer, D.; Coleman, L.W.; Leppert, M.; Slattery, M.L. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001, 10, 917–923. [Google Scholar] [PubMed]
- Ribic, C.M.; Sargent, D.J.; Moore, M.J.; Thibodeau, S.N.; French, A.J.; Goldberg, R.M.; Hamilton, S.R.; Laurent- Puig, P.; Gryfe, R.; Shepherd, L.E.; Tu, D.; Redston, M.; Gallinger, S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003, 349, 247–257. [Google Scholar] [CrossRef] [PubMed]
- Carethers, J.M.; Smith, E.J.; Behling, C.A.; Nguyen, L.; Tajima, A.; Doctolero, R.T.; Cabrera, B.L.; Goel, A.; Arnold, C.A.; Miyai, K.; Boland, C.R. Use of 5- fluorouracil and survival in patients with microsatellite unstable colorectal cancer. Gastroenterology 2004, 126, 394–401. [Google Scholar] [CrossRef] [PubMed]
- Constantin, V.D.; Socea, B.; Popa, F.; Carâp, A.C.; Popescu, G.; Vlădescu, T.; Ceauşu, Z.; Berteşteanu, Ş.V.; Ceauşu, M.C. A histopathological and immunohistochemical approach of surgical emergencies of GIST. An interdisciplinary study. Rom J Morphol Embryol 2014, 55(2 Suppl), 619-27. [Google Scholar]
- Ishikawa, T.; Fujita, T.; Suzuki, Y.; Okabe, S.; Yuasa, Y.; Iwai, T.; Kawakami, Y. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res. 2003, 63, 5564–5572. [Google Scholar] [PubMed]
- Baker, K.; Zlobec, I.; Tornillo, L.; Terracciano, L.; Jass, J.R.; Lugli, A. Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway. Eur J Cancer. 2007, 43, 624–631. [Google Scholar] [CrossRef] [PubMed]
- Speetjens, F.M.; de Bruin, E.C.; Morreau, H.; Zeestraten, E.C.; Putter, H.; van Krieken, J.H.; van Buren, M.M.; van Velzen, M.; Dekker-Ensink, N.G.; van de Velde, C.J.; Kuppen, P.J. Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother. 2008, 57, 601–609. [Google Scholar] [CrossRef] [PubMed]
- Târtea, E.A.; Florescu, C.; Donoiu, I.; Pirici, D.; Mihailovici, A.R.; Albu, V.C.; Bălşeanu, T.A.; Iancău, M.; Badea, C.D.; Vere, C.C.; Sfredel, V. Implications of inflammation and remodeling of the enteric glial cells in colorectal adenocarcinoma. Rom J Morphol Embryol. 2017, 58, 473–480. [Google Scholar] [PubMed]
- Zheng, J.; Huang, B.; Nie, X.; Zhu, Y.; Han, N.; Li, Y. The clinicopathological features and prognosis of tumor MSI in East Asian colorectal cancer patients using NCI panel. Future Oncol 2018. [Epub ahead of print]. [Google Scholar] [CrossRef] [PubMed]
- Le, D.T.; Uram, J.N.; Wang, H.; Bartlett, B.R.; Kemberling, H.; Eyring, A.D.; Skora, A.D.; Luber, B.S.; Azad, N.S.; Laheru, D.; et al. PD-1 blockade in tumors with Missmatch-Repair Deficiency. N Engl J Med 2015, 372, 2509–2520. [Google Scholar] [CrossRef] [PubMed]
- Overman, M.J.; Lonardi, S.; Wong, K.Y.M.; Lenz, H.J.; Gelsomino, F.; Aglietta, M.; Morse, M.A.; Van Cutsem, E.; McDermott, R.; Hill, A.; Sawyer, M.B.; Hendlisz, A.; Neyns, B.; Svrcek, M.; Moss, R.A.; Ledeine, J.M.; Cao, Z.A.; Kamble, S.; Kopetz, S.; André, T. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. J Clin Oncol 2018. Epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Westdorp, H.; Fennemann, F.L.; Weren, R.D.; Bisseling, T.M.; Ligtenberg, M.J.; Figdor, C.G.; Schreibelt, G.; Hoogerbrugge, N.; Wimmers, F.; de Vries, I.J. Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol Immunother. 2016, 65, 1249–1259. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the author. 2018 Adrian Tulin, Iulian Slavu, Raluca Tulin, Lucian Alecu, Radu C. Jecan, Cristina Orlov, Cristian I. Iaciu, Dana L. Stanculeanu, Razvan Hainarosie, Silviu Pituru, Anca Pantea Stoian, Cornelia Nitipir
Share and Cite
Tulin, A.; Slavu, I.; Tulin, R.; Alecu, L.; Jecan, R.C.; Orlov, C.; Iaciu, C.I.; Stanculeanu, D.L.; Hainarosie, R.; Pituru, S.; et al. Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer? J. Mind Med. Sci. 2018, 5, 101-108. https://doi.org/10.22543/7674.51.P101108
Tulin A, Slavu I, Tulin R, Alecu L, Jecan RC, Orlov C, Iaciu CI, Stanculeanu DL, Hainarosie R, Pituru S, et al. Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer? Journal of Mind and Medical Sciences. 2018; 5(1):101-108. https://doi.org/10.22543/7674.51.P101108
Chicago/Turabian StyleTulin, Adrian, Iulian Slavu, Raluca Tulin, Lucian Alecu, Radu C. Jecan, Cristina Orlov, Cristian I. Iaciu, Dana L. Stanculeanu, Razvan Hainarosie, Silviu Pituru, and et al. 2018. "Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer?" Journal of Mind and Medical Sciences 5, no. 1: 101-108. https://doi.org/10.22543/7674.51.P101108
APA StyleTulin, A., Slavu, I., Tulin, R., Alecu, L., Jecan, R. C., Orlov, C., Iaciu, C. I., Stanculeanu, D. L., Hainarosie, R., Pituru, S., Pantea Stoian, A., & Nitipir, C. (2018). Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer? Journal of Mind and Medical Sciences, 5(1), 101-108. https://doi.org/10.22543/7674.51.P101108